Immunoscience Clinical Trial
Official title:
Placebo-Controlled, Double-Blind, Ascending Single and Multiple Oral Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-791826 and to Assess Its Marker Specific Pharmacodynamics in Relation to Prednisolone in Healthy Males
The purpose of this study is to evaluate the safety, PK, PD, of BMS-791826 and to assess its marker specific PD in relation to Prednisolone in healthy male subjects
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03196557 -
A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject
|
Phase 1 |